Quality of life assessment of relapsing-remitting multiple sclerosis patients on long-term treatment with Betaferon

被引：0
作者：
Davidescu, I.
Damian, G.
机构：
[1] Colentina Hosp, Dept Neurol, Bucharest, Romania
[2] UMF Carol Davila, Bucharest, Romania
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [41] Development of a nursing tool, STEPS, to assess long-term treatment adherence in relapsing-remitting multiple sclerosis
    Harris, C
    Lowden, D
    MULTIPLE SCLEROSIS, 2005, 11 : S99 - S99
  • [42] LONG-TERM INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - 3 YEARS EXPERIENCE
    ACHIRON, A
    ZIV, I
    GILAD, R
    DJALDETTI, R
    ZOLDAN, Y
    SAROVAPINHAS, I
    MELAMED, E
    ANNALS OF NEUROLOGY, 1993, 34 (02) : 275 - 275
  • [43] Health related quality of life as an independent predictor of long-term disability for patients with relapsing remitting multiple sclerosis
    Baumstarck, Karine
    Pelletier, Jean
    Butzkueven, Helmut
    Fernandez, Oscar
    Flachenecker, Peter
    Idiman, Egemen
    Stecchi, Sergio
    Auquier, Pascal
    QUALITY OF LIFE RESEARCH, 2012, 21 : 118 - 118
  • [44] Residual adaptive inflammation in the cerebrospinal fluid after long-term natalizumab treatment in patients with relapsing-remitting multiple sclerosis
    Buhelt, Sophie
    Hansen, Malene Bredahl
    Soendergaard, Helle Bach
    El Mahdaoui, Sahla
    Hansen, Marie Mathilde
    Mahler, Mie Reith
    Christensen, Jeppe Romme
    Sellebjerg, Finn
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 580 - 580
  • [45] Immune response to seasonal influenza vaccine in patients with relapsing-remitting multiple sclerosis on long-term daclizumab HYP treatment
    Mehta, L.
    Priestley, R.
    Umans, K.
    Ozen, G.
    Robinson, R.
    Sweetser, M.
    Elkins, J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 234 - 235
  • [46] Long-term effect of fingolimod on cardiovascular functioning in people with relapsing-remitting multiple sclerosis
    Haase, R.
    Forberger, C.
    Schilling, M.
    Piatkowski, F.
    Akgun, K.
    Rudiger, H.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 609 - 610
  • [47] Long-term MRI observations of childhood-onset relapsing-remitting multiple sclerosis
    Balássy, C
    Bernert, G
    Wöber-Bingöl, C
    Csapó, B
    Kornek, B
    Széles, J
    Fleischmann, D
    Prayer, D
    NEUROPEDIATRICS, 2001, 32 (01) : 28 - 37
  • [48] Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis
    Maggi, Gianpaolo
    Altieri, Manuela
    Risi, Mario
    Rippa, Valentina
    Borgo, Riccardo Maria
    Lavorgna, Luigi
    Bonavita, Simona
    Buonanno, Daniela
    D'Ambrosio, Alessandro
    Bisecco, Alvino
    Santangelo, Gabriella
    Tessitore, Alessandro
    Gallo, Antonio
    MULTIPLE SCLEROSIS JOURNAL, 2025, 31 (01) : 107 - 116
  • [49] Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis Patients
    Chan, Jillian K.
    de Lapiscina, Elena Hernandez Martinez
    Taylor, Carolyn
    Nguyen, Ai-Lan
    Alba-Arbalat, Salut
    Devonshire, Virginia
    Sayao, Ana-Luiza
    Carruthers, Robert
    Costello, Fiona
    Traboulsee, Anthony
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2020, 40 (01) : 37 - 43
  • [50] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
12345